美国结肠镜腺瘤检出率基准:基于全国注册研究
研究基于2014至2018年美国GI质量改进联盟注册的2,646,833例50-89岁成人结肠镜检查,评估腺瘤检出率(ADR)的变异性及影响因素。内镜医师平均筛查ADR为36.80%(SD 10.21),男性44.08%(SD 10.98),女性31.20%(SD 9.65),美国人口标准化后为39.08%。筛查ADR从2014年33.93%显著升至2018年38.12%。
要点
- 美国全国样本标准化ADR为39.08%,筛查ADR随时间显著提高。
- 内镜医师平均筛查ADR为36.80%,男性高于女性。
- ADR在不同内镜医师间存在较大变异(SD约10%)。
核心结论
- 美国大型全国样本标准化腺瘤检出率平均为39.05%,且随时间呈上升趋势。
研究设计与样本
- 回顾性注册研究,纳入2014至2018年GI质量改进联盟注册的2,646,833例50-89岁成人结肠镜检查,由1,169名内镜医师完成,采用分层logistic模型分析影响因素。
主要发现
- 内镜医师平均筛查ADR为36.80%(SD 10.21),男性44.08%(SD 10.98),女性31.20%(SD 9.65)。
- 美国人口标准化后ADR为39.08%。
- 筛查ADR从2014年33.93%显著上升至2018年38.12%。
临床怎么用
- 该全国基准数据可用于内镜医师ADR的质量评估与对标改进。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Adenoma detection rate (ADR) is highly variable across practices, and national or population-based estimates are not available. Our aim was to study the ADR, variability of rates over time, and factors associated with detection rates of ADR in a national sample of patients undergoing colonoscopy. METHODS: We used colonoscopies submitted to the GI Quality Improvement Consortium, Ltd. registry from 2014 to 2018 on adults aged 50-89 years. We used hierarchical logistic models to study factors associated with ADR. RESULTS: A total of 2,646,833 colonoscopies were performed by 1,169 endoscopists during the study period. The average ADR for screening colonoscopies per endoscopist was 36.80% (SD 10.21), 44.08 (SD 10.98) in men and 31.20 (SD 9.65) in women. Adjusted to the US population, the ADR was 39.08%. There was a significant increase in ADR from screening colonoscopies over the study period from 33.93% in 2014 to 38.12% in 2018. DISCUSSION: The average ADR from a large national US sample standardized to the US population is 39.05% and has increased over time.
引用
- Shaukat A, Holub J, Pike IM, et al. Benchmarking Adenoma Detection Rates for Colonoscopy: Results From a US-Based Registry. Am J Gastroenterol. 2021. PMID: 34158463. doi:10.14309/ajg.0000000000001358
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。